Replies to post #7909 on Halozyme Therapeutics Inc (HALO)

[stockrafter]

Yes, we know, "MK-5108 is a potent/highly selective Aurora A kinase inhibitor," not a hyalurondase.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806784/

"MK-3475A ..... it is a fixed dose formulation of pembrolizumab and MK-5180 and is administered through subcutaneous route."

https://www.pharmaceutical-technology.com/data-insights/mk-3475a-merck-metastatic-melanoma-likelihood-of-approval-2/?cf-view